Work

Elotuzumab in Combination with an Immunomodulatory Agent (IMID) in Patients with Multiple Myeloma Refractory to Imids and/or Daratumumab: A Single-Institution Analysis

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-129021

Authors: Ariel F Grajales-Cruz, Cristian Ivan Rodriguez Arocho, Ashley Rose, Jamie Shapiro, Elizabeth Finley-Oliver, Kenneth H. Shain, Jason B. Brayer, Taiga Nishihori, Leonel Ochoa, Omar Alexis Castaneda Puglianini, Melissa Alsina, Rachid Baz

Institutions: University of South Florida, Moffitt Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2985087161

Cites:

Cited by: 8

Related to: 10